329 related articles for article (PubMed ID: 26297673)
1. Targeting oxidant-dependent mechanisms for the treatment of COPD and its comorbidities.
Bernardo I; Bozinovski S; Vlahos R
Pharmacol Ther; 2015 Nov; 155():60-79. PubMed ID: 26297673
[TBL] [Abstract][Full Text] [Related]
2. New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease.
Brassington K; Selemidis S; Bozinovski S; Vlahos R
Clin Sci (Lond); 2019 Apr; 133(7):885-904. PubMed ID: 30979844
[TBL] [Abstract][Full Text] [Related]
3. Comorbidities of chronic obstructive pulmonary disease.
Corsonello A; Antonelli Incalzi R; Pistelli R; Pedone C; Bustacchini S; Lattanzio F
Curr Opin Pulm Med; 2011 Dec; 17 Suppl 1():S21-8. PubMed ID: 22209926
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of comorbidities in COPD patients by disease severity in a German population.
Greulich T; Weist BJD; Koczulla AR; Janciauskiene S; Klemmer A; Lux W; Alter P; Vogelmeier CF
Respir Med; 2017 Nov; 132():132-138. PubMed ID: 29229085
[TBL] [Abstract][Full Text] [Related]
5. Preclinical murine models of Chronic Obstructive Pulmonary Disease.
Vlahos R; Bozinovski S
Eur J Pharmacol; 2015 Jul; 759():265-71. PubMed ID: 25818750
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy.
Kirkham P; Rahman I
Pharmacol Ther; 2006 Aug; 111(2):476-94. PubMed ID: 16458359
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic prospects to treat skeletal muscle wasting in COPD (chronic obstructive lung disease).
Hansen MJ; Gualano RC; Bozinovski S; Vlahos R; Anderson GP
Pharmacol Ther; 2006 Jan; 109(1-2):162-72. PubMed ID: 16154635
[TBL] [Abstract][Full Text] [Related]
8. Comorbidity in chronic obstructive pulmonary disease.
Negewo NA; McDonald VM; Gibson PG
Respir Investig; 2015 Nov; 53(6):249-58. PubMed ID: 26521102
[TBL] [Abstract][Full Text] [Related]
9. The chronic obstructive pulmonary disease comorbidity spectrum in Japan differs from that in western countries.
Takahashi S; Betsuyaku T
Respir Investig; 2015 Nov; 53(6):259-70. PubMed ID: 26521103
[TBL] [Abstract][Full Text] [Related]
10. Systemic manifestations and comorbidities of COPD.
Barnes PJ; Celli BR
Eur Respir J; 2009 May; 33(5):1165-85. PubMed ID: 19407051
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress and free radicals in COPD--implications and relevance for treatment.
Domej W; Oettl K; Renner W
Int J Chron Obstruct Pulmon Dis; 2014; 9():1207-24. PubMed ID: 25378921
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress and gene transcription in asthma and chronic obstructive pulmonary disease: antioxidant therapeutic targets.
Rahman I
Curr Drug Targets Inflamm Allergy; 2002 Sep; 1(3):291-315. PubMed ID: 14561194
[TBL] [Abstract][Full Text] [Related]
13. Emerging therapies for the treatment of skeletal muscle wasting in chronic obstructive pulmonary disease.
Passey SL; Hansen MJ; Bozinovski S; McDonald CF; Holland AE; Vlahos R
Pharmacol Ther; 2016 Oct; 166():56-70. PubMed ID: 27373503
[TBL] [Abstract][Full Text] [Related]
14. [Comorbidities with COPD].
Hashimoto S; Gon Y; Mizumura K
Nihon Rinsho; 2016 May; 74(5):850-7. PubMed ID: 27254958
[TBL] [Abstract][Full Text] [Related]
15. Vascular dysfunction in chronic obstructive pulmonary disease: current evidence and perspectives.
Clarenbach CF; Thurnheer R; Kohler M
Expert Rev Respir Med; 2012 Feb; 6(1):37-43. PubMed ID: 22283577
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and burden of comorbidities in Chronic Obstructive Pulmonary Disease.
Corlateanu A; Covantev S; Mathioudakis AG; Botnaru V; Siafakas N
Respir Investig; 2016 Nov; 54(6):387-396. PubMed ID: 27886849
[TBL] [Abstract][Full Text] [Related]
17. [Chronic obstructive pulmonary disease and cardiovascular system].
Gürgün A; Gürgün C
Tuberk Toraks; 2008; 56(4):464-71. PubMed ID: 19123087
[TBL] [Abstract][Full Text] [Related]
18. ROS in the local and systemic pathogenesis of COPD.
Langen RC; Korn SH; Wouters EF
Free Radic Biol Med; 2003 Aug; 35(3):226-35. PubMed ID: 12885585
[TBL] [Abstract][Full Text] [Related]
19. Oxidation pathway and exacerbations in COPD: the role of NAC.
Matera MG; Calzetta L; Cazzola M
Expert Rev Respir Med; 2016; 10(1):89-97. PubMed ID: 26567752
[TBL] [Abstract][Full Text] [Related]
20. Oxidants/antioxidants and chronic obstructive pulmonary disease: pathogenesis to therapy.
MacNee W
Novartis Found Symp; 2001; 234():169-85; discussion 185-8. PubMed ID: 11199095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
